MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NCT:NCT05794880 · RECRUITING
廣告
NCT IDNCT05794880
狀態RECRUITING
開始日期2023-05-01
SponsorMedical College of Wisconsin (OTHER)
First posted
Last updated
簡要摘要
This is a single arm pilot study for patients with hematologic malignancies receiving unrelated or haploidentical related mobilized peripheral stem cells (PSCs) using the CliniMACS system for alpha/beta T cell depletion plus CD19+ B cell depletion with individualized ALC-based dosing of ATG to study impact on engraftment, GVHD, and disease free survival
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。